Nanexa signs a “Technology Evaluation Agreement” with a global equipment company for technology evaluation and upscaling of the PharmaShell® process.
Pressrelease
Uppsala 24th January 2020
Nanexa signs a “Technology Evaluation Agreement” with a global equipment company for technology evaluation and upscaling of the PharmaShell® process.
The US Patent Office has approved Nanexa’s expanded patent application for the drug delivery platform PharmaShell®.
Uppsala 19th November 2019
The US Patent Office has approved Nanexa’s expanded patent application for the drug delivery platform PharmaShell®.
The US Patent Office has today approved another patent application for Nanexa.